Identification of Transcriptomic Signatures of Pancreatic Ductal Adenocarcinoma-Derived Exosomes That Promote Macrophage M2 Polarization and Predict Prognosis: S100A9 Reveals Tumor Progression.

导出 LinkOut

翻译打印收藏纠错

作者： Siyuan,Tan ^[1] ; Haodong,Tang ^[1] ; Zheng,Zhang ^[1] ; Yang,Wang ^[1] ; Haifeng,Li ^[2] ; Wenyuan,Shi ^[1] ; Hao,Ye ^[2] ; Peng,Xie ^[1] ; Jiahua,Zhou ^[1]

作者单位： Department of Surgery, School of Medicine, Southeast University, Nanjing, China. ^[1] Department of Hepato-Pancreatico-Biliary Surgery, Zhongda Hospital Southeast University, Nanjing, China. ^[2]

关键词 M2 macrophages Pancreatic ductal adenocarcinoma exosome immunization prognosis risk score model

DOI 10.1177/11795549241239042

PMID 38510315

发布时间 2024-03-22

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Clinical Medicine Insights. Oncology

2024年18卷

11795549241239042页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Identification of Transcriptomic Signatures of Pancreatic Ductal Adenocarcinoma-Derived Exosomes That Promote Macrophage M2 Polarization and Predict Prognosis: S100A9 Reveals Tumor Progression.

Clinical Medicine Insights. Oncology

相似文献

Clinical Medicine Insights. Oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Identification of Transcriptomic Signatures of Pancreatic Ductal Adenocarcinoma-Derived Exosomes That Promote Macrophage M2 Polarization and Predict Prognosis: S100A9 Reveals Tumor Progression.

Clinical Medicine Insights. Oncology

相似文献

Clinical Medicine Insights. Oncology

相关期刊

检索历史清除